| Inhaled iloprost for therapy in pulmonary arterial hypertension. | |
| | |
MedLine Citation:
|
PMID: 21510725 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Iloprost (Ventavis(®), Bayer Schering Pharma, Germany) is a synthetic prostacyclin that is used in its inhalative form for the therapy of pulmonary arterial hypertension. Long-term therapy can increase exercise capacity and quality of life. The use of modern nebulizers especially designed for the administration of iloprost guarantees the pulmonary deposition of the required doses and systematically minimizes side effects. Regarding existing data, inhalative iloprost acts in effective and safe combination with other classes of medication; indeed, such combination therapy is frequently necessary in pulmonary arterial hypertension. |
| | |
Authors:
|
Ralf Ewert; Sven Gläser; Tom Bollmann; Christoph Schäper |
Related Documents
:
|
105585 - Calibrated leak balloon microcatheter: a device for arterial exploration and occlusive ... 21326515 - Uterine artery embolization: a safe and effective, minimally invasive, uterine-sparing ... 2144535 - Aneurysm mimicking intracranial growth of optic nerve sheath meningioma. 15633985 - Estimating the annual rate of de novo multiple aneurysms: three statistical approaches. 18202905 - Experience of robotic catheter ablation in humans using a novel remotely steerable cath... 16799315 - A hemodynamic study of the effects of arterial anastomoses with interrupted simple vers... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert review of respiratory medicine Volume: 5 ISSN: 1747-6356 ISO Abbreviation: Expert Rev Respir Med Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-04-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278196 Medline TA: Expert Rev Respir Med Country: England |
Other Details:
|
Languages: eng Pagination: 145-52 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine, Ernst-Moritz-Arndt University, Greifswald, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Xanthine oxidase inhibitors: a patent survey.
Next Document: Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.